71 related articles for article (PubMed ID: 37996944)
1. Lipidomics reveals new lipid-based lung adenocarcinoma early diagnosis model.
Sun T; Chen J; Yang F; Zhang G; Chen J; Wang X; Zhang J
EMBO Mol Med; 2024 Apr; 16(4):854-869. PubMed ID: 38467839
[TBL] [Abstract][Full Text] [Related]
2. Spatial transcriptomics reveals heterogeneity of histological subtypes between lepidic and acinar lung adenocarcinoma.
Xie L; Kong H; Yu J; Sun M; Lu S; Zhang Y; Hu J; Du F; Lian Q; Xin H; Zhou J; Wang X; Powell CA; Hirsch FR; Bai C; Song Y; Yin J; Yang D
Clin Transl Med; 2024 Feb; 14(2):e1573. PubMed ID: 38318637
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of lung adenocarcinoma transcriptome with signature of tobacco exposure.
Hammouz RY; Kostanek JK; Dudzisz A; Witas P; Orzechowska M; Bednarek AK
J Appl Genet; 2020 Sep; 61(3):421-437. PubMed ID: 32564237
[TBL] [Abstract][Full Text] [Related]
4. Architecting the metabolic reprogramming survival risk framework in LUAD through single-cell landscape analysis: three-stage ensemble learning with genetic algorithm optimization.
Sun X; Nong M; Meng F; Sun X; Jiang L; Li Z; Zhang P
J Transl Med; 2024 Apr; 22(1):353. PubMed ID: 38622716
[TBL] [Abstract][Full Text] [Related]
5. Single-cell analyzing of tumor microenvironment and cell adhesion between early and late-stage lung cancer.
Zhu C; Chen Z; Wang S; Cao J; Cheng Y; Zheng M
Mol Immunol; 2024 May; 171():1-11. PubMed ID: 38696904
[TBL] [Abstract][Full Text] [Related]
6. Differential GPR56 Expression in T Cell Subpopulations for Early-Stage Lung Adenocarcinoma Patient Identification.
Ren J; Zhu Y; Nie Y; Zheng M; Hasimu A; Zhao M; Zhao Y; Ma X; Yuan Z; Li Q; Bahabayi A; Zhang Z; Zeng X; Liu C
Immunol Invest; 2024 May; ():1-14. PubMed ID: 38809082
[TBL] [Abstract][Full Text] [Related]
7. The evolution of lung adenocarcinoma precursors is associated with chromosomal instability and transition from innate to adaptive immune response/evasion.
Hu X; Zhu B; Vokes N; Fujimoto J; Rojas Alvarez FR; Heeke S; Moreira AL; Solis LM; Haymaker C; Velcheti V; Sterman DH; Pass HI; Cheng C; Lee JJ; Zhang J; Wei Z; Wu J; Le X; Ostrin E; Toumazis I; Gibbons D; Su D; Fukuoka J; Antonoff MB; Gerber DE; Li C; Kadara H; Wang L; Davis M; Heymach JV; Hannash S; Wistuba I; Dubinett S; Alexandrov L; Lippman S; Spira A; Futreal AP; Reuben A; Zhang J
Res Sq; 2024 May; ():. PubMed ID: 38798564
[TBL] [Abstract][Full Text] [Related]
8. Expression of GPR56 reflects a hypoactivated state of circulating B cells and is downregulated in B cell subsets in patients with early-stage lung adenocarcinoma.
Bahabayi A; Guan Z; Zheng M; Yu H; Hasimu A; Nie Y; Zhao M; Zhu Y; Ren J; Zhao Y; Ma X; Li Q; Zhang Z; Zeng X; Liu C
Immunology; 2024 Jun; ():. PubMed ID: 38840413
[TBL] [Abstract][Full Text] [Related]
9. CRACD loss induces neuroendocrine cell plasticity of lung adenocarcinoma.
Kim B; Zhang S; Huang Y; Ko KP; Jung YS; Jang J; Zou G; Zhang J; Jun S; Kim KB; Park KS; Park JI
Cell Rep; 2024 May; 43(6):114286. PubMed ID: 38796854
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological analysis of bronchiolar adenoma combined with lung adenocarcinoma: Report of eight cases and literature review.
Zhu M; Yang Q; Zhan S; Liu W; Liu W; Guo L; Huang S
Histol Histopathol; 2024 Jun; 39(6):783-794. PubMed ID: 38059279
[TBL] [Abstract][Full Text] [Related]
12. Transcriptomic landscape based on annotated clinical features reveals PLPP2 involvement in lipid raft-mediated proliferation signature of early-stage lung adenocarcinoma.
Wang Y; Miao Z; Qin X; Yang Y; Wu S; Miao Q; Li B; Zhang M; Wu P; Han Y; Li B
J Exp Clin Cancer Res; 2023 Nov; 42(1):315. PubMed ID: 37996944
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
14. Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinoma.
Cheng WC; Chang CY; Lo CC; Hsieh CY; Kuo TT; Tseng GC; Wong SC; Chiang SF; Huang KC; Lai LC; Lu TP; Chao KSC; Sher YP
Theranostics; 2021; 11(8):3661-3675. PubMed ID: 33664854
[No Abstract] [Full Text] [Related]
15. Immune landscape and a novel immunotherapy-related gene signature associated with clinical outcome in early-stage lung adenocarcinoma.
Bao X; Shi R; Zhao T; Wang Y
J Mol Med (Berl); 2020 Jun; 98(6):805-818. PubMed ID: 32333046
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
